Context Therapeutics (6K9.F) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.14
-0.09
-0.03

Details

Expected EPS
-0.051281860000000005
Actual EPS
-0.044208500000000005
Surprise EPS
0.01
Surprise Percent
+13.79%

Description

Context Therapeutics (6K9.F) has reported earnings of -0.044208500000000005 per share for Q2 2025.

0 Comments

Share your thoughts